Steady remission of scleromyxedema 3 years after autologous stem cell transplantation: an in vivo and in vitro study.
Illa
Isabel
I
de la Torre
Carolina
C
Rojas-Garcia
Ricardo
R
Altes
Antoni
A
Blesa
Rafael
R
Sierra
Jordi
J
Gallardo
Eduard
E
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003240:Connective Tissue Diseases / Q000628:therapy; D018572:Disease-Free Survival; D005347:Fibroblasts / Q000737:chemistry; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D008297:Male; D009230:Myxedema / Q000628:therapy*; D011506:Proteins / Q000032:analysis; D012074:Remission Induction; D014182:Transplantation, Autologous
D011506:Proteins